Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Neuro-Oncology Advances|June 22, 2023
Leptomeningeal disease in histone-mutant gliomasMaria Diaz, Satshil Rana, Carlos Eduardo Silva Correia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2018
The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinomaSnjezana Dogan, Denise Frosina, Miriam Fayad, et al.
The Journal of Pathology|September 30, 2024
Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusionsJoanna Cyrta, Josephine K Dermawan, Arnault Tauziède-Espariat, et al.
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and NivolumabAndrew L Lin, Philip Jonsson, Viviane Tabar, et al.
Neuro-Oncology|January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient seriesAnkush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
Archives of Pathology & Laboratory Medicine|June 8, 2026
Interobserver Variability Across Whole-Slide Imaging SystemsBenzion Samueli, Hikmat Al-Ahmadie, Marina Baine, et al.
Pediatric Blood & Cancer|July 29, 2006
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescueStergios Zacharoulis, Adam Levy, Susan N Chi, et al.
Journal of Neuro-Oncology|June 8, 2020
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancerRachna Malani, Martin Fleisher, Priya Kumthekar, et al.
Journal of Neuro-Oncology|February 28, 2023
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymomaKathryn R Tringale, Suzanne L Wolden, Matthias Karajannis, et al.
Pediatric Blood & Cancer|August 3, 2007
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experienceJason Fangusaro, Jonathan Finlay, Richard Sposto, et al.
Pageof 8